Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers
Titel:
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers
Auteur:
Mathur, Mohit Barratt, Jonathan Suzuki, Yusuke Engler, Frank Pasetti, Marcela F. Yarbrough, Jill Sloan, Susan Oldach, David